American Association for Cancer Research

SHERPA: Unknown

People

  1. Kris
    Kris
  2. Ladanyi
    Ladanyi
  3. Riely
    Riely
  4. Arcila
    Arcila
  5. Sirotnak
    Sirotnak
  6. Drilon
    Drilon
  7. Rudin
    Rudin
  8. Rusch
    Rusch
  9. Scher
    Scher
  10. Chaft
    Chaft

Groups

  1. Department of Medicine (76)
  2. Solid Tumor Oncology Division (76)
  3. Thoracic Oncology (76)
  4. GSK Faculty (44)
  5. Department of Pathology and Laboratory Medicine (40)
  6. Human Oncology and Pathogenesis Program (35)
  7. Tow Center for Developmental Oncology (TCDO) (35)
  8. Epidemiology and Biostatistics (19)
  9. Radiology, Department of (18)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (17)
Search Within
  1. "Mark Kris"
Formats
  1. Journal Article (61)
  2. Meeting Abstract (15)
Groups
  1. Department of Medicine (76)
  2. Solid Tumor Oncology Division (76)
  3. Thoracic Oncology (76)
  4. GSK Faculty (44)
  5. Department of Pathology and Laboratory Medicine (40)
  6. Human Oncology and Pathogenesis Program (35)

More Groups

People
  1. Mark Kris (76)
  2. Marc Ladanyi (33)
  3. Vincent Miller (32)
  4. Gregory Riely (26)
  5. Maria Arcila (23)
  6. Francis Sirotnak (16)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2021 (3)
  4. 2020 (5)
  5. 2019 (3)
  6. 2018 (3)

More Years

Publications
  1. Clinical Cancer Research (65)
  2. Cancer Research (11)

Results (76)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer
    Journal Article

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Brief report: Combination of osimertinib and dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas
    Journal Article

    Elkrief, A.; Makhnin, A.; Moses, K. A.; Ahn, L. S.; Preeshagul, I. R.; Iqbal, A. N.; Hayes, S. A.; Plodkowski, A. J.; Paik, P. K.; Ladanyi, M.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Response to standard therapies and comprehensive genomic analysis for patients with lung adenocarcinoma with EGFR exon 20 insertions
    Journal Article

    Choudhury, N. J.; Schoenfeld, A. J.; Flynn, J.; Falcon, C. J.; Rizvi, H.; Rudin, C. M.; Kris, M. G.; Arcila, M. E.; Heller, G.; Yu, H. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Treatment outcomes and clinical characteristics of patients with KRAS-G12C-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Hellmann, M. D.; Knezevic, A.; Heller, G.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • MET exon 14-altered lung cancers and MET inhibitor resistance
    Journal Article

    Guo, R.; Offin, M.; Brannon, A. R.; Chang, J.; Chow, A.; Delasos, L.; Girshman, J.; Wilkins, O.; McCarthy, C. G.; Makhnin, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • COVID-19 in patients with lung cancers in New York City
    Meeting Abstract

    Luo, J.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Hoyos, D.; Bandlamudi, C.; Donoghue, M. T. A.; Łuksza, M.; Greenbaum, B. D.; Wolchok, J. D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC
    Journal Article

    Hellmann, M. D.; Nabet, B. Y.; Rizvi, H.; Chaudhuri, A. A.; Wells, D. K.; Dunphy, M. P. S.; Chabon, J. J.; Liu, C. L.; Hui, A. B.; Arbour, K. C.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Tumor analyses reveal squamous transformation and off-target alterations as early resistance mechanisms to first-line osimertinib in EGFR-mutant lung cancer
    Journal Article

    Schoenfeld, A. J.; Chan, J. M.; Kubota, D.; Sato, H.; Rizvi, H.; Daneshbod, Y.; Chang, J. C.; Paik, P. K.; Offin, M.; Arcila, M. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • MAPK pathway alterations correlate with poor survival and drive resistance to therapy in patients with lung cancers driven by ROS1 fusions
    Journal Article

    Sato, H.; Schoenfeld, A. J.; Siau, E.; Lu, Y. C.; Tai, H.; Suzawa, K.; Kubota, D.; Lui, A. J. W.; Qeriqi, B.; Mattar, M.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: